Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice.

about

Enhanced operant extinction and prefrontal excitability in a mouse model of Angelman syndrome.Chemoprevention of LA7-Induced Mammary Tumor Growth by SM6Met, a Well-Characterized Cyclopia Extract.

P2860

Q50066459-437E196C-9F6A-4AEB-964D-F9B004DE0B8B Q55455104-0E749CDE-9AF5-46D7-9AC1-357CD0908205

P2860

Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice.

Item

http://www.wikidata.org/entity/Q36502027

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Tamoxifen induces hepatotoxici ...... e of endocrinotherapy in mice.

@ast

Tamoxifen induces hepatotoxici ...... e of endocrinotherapy in mice.

@en

type

Item

label

Tamoxifen induces hepatotoxici ...... e of endocrinotherapy in mice.

@ast

Tamoxifen induces hepatotoxici ...... e of endocrinotherapy in mice.

@en

prefLabel

Tamoxifen induces hepatotoxici ...... e of endocrinotherapy in mice.

@ast

Tamoxifen induces hepatotoxici ...... e of endocrinotherapy in mice.

@en

P1476

Tamoxifen induces hepatotoxici ...... e of endocrinotherapy in mice.

@en

P2093

Fang-Fang Gao

http://www.w3.org/2001/XMLSchema#string

Jia-Wei Lv

http://www.w3.org/2001/XMLSchema#string

Lei Wei

http://www.w3.org/2001/XMLSchema#string

Qun Li

http://www.w3.org/2001/XMLSchema#string

Rong Fan

http://www.w3.org/2001/XMLSchema#string

Ying Wang

http://www.w3.org/2001/XMLSchema#string

Zun Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective identification of tumorigenic breast cancer cells

Molecular portraits of human breast tumours

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

Combination treatment of tamoxifen with risperidone in breast cancer

Cell migration: Rho GTPases lead the way

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients.

Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.

Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

P304

102-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/BR.2015.536

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283478570

http://www.w3.org/2001/XMLSchema#string

P698

26870344

http://www.w3.org/2001/XMLSchema#string

P921

hepatotoxicity

P932

4726841

http://www.w3.org/2001/XMLSchema#string

Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice.

about

P2860

P2860

Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932